Clinical Trial Update: Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing Natesto effects on testosterone, LH, FSH, and semen parameters in males with hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism Male

Drugs mentioned

• NATESTO (testosterone)

Snippet

Sponsor: University of Miami | Conditions: Hypogonadism, Male | Phase 4 | Status: COMPLETED | Results posted: 2021-08-23